Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: Clinical evaluation and laboratory investigation
Auris Nasus Larynx, 02/04/2011
Clinical Article
Fu Y et al. – Intratympanic dexamethasone at 5 mg/ml did not add effect to systemic steroids in improving hearing outcomes in patients with idiopathic sudden sensorineural hearing loss.



